GlaxoSmithKline Pharmaceuticals Limited Stock (NSE:GLAXO)

INDIA |NSE |INR

Price
INR 1,500.00
Change
-0.47%
Today's Range
INR1,497.20 - INR1,521.80
52-Week Range
INR1,449.20 - INR1,918.75
Market Cap
INR254.56B
Volume
19.10K

About Glaxosmithkline Pharmaceuticals Limited (NSE:GLAXO)

(NSE:GLAXO) GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for asthma, infectious diseases, mental health, and digestive conditions, as well as anti-infective, gastrointestinal, nutrition, dermatology, immuno-inflammation, and respiratory diseases. It also provides vaccines for the treatment of cancer, as well as prevention of hepatitis A, hepatitis B, invasive disease caused by influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, invasive pneumococcal, and others; and consumer healthcare products. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is headquartered in Mumbai, India.
Show more

GLAXO Stock Price

Statistics Highlights (NSE:GLAXO)

Shares Outstanding 169.41M Beta 0.18
Public Float 41.43M P/E Ratio 15.00
% Short of Float - Dividend (Yield) 30.00 (0.02%)
Held by Insiders 75.54% Ex-Dividend Date Jul 7, 2022
Held by Institutions 11.68% IPO Date -

GLAXO Financial Summary

|
Mar 22 Mar 21 Mar 20
Revenue INR32.78B INR31.99B INR32.24B
EBITDA INR8.49B INR6.33B INR3.95B
Net Income INR16.95B INR3.58B INR932.05M
Total Assets INR46.33B INR31.13B INR31.36B
Total Cash INR2.86B INR4.05B INR1.05B
Total Debt INR INR346.27M INR418.40M
Mar 22 Dec 21 Sep 21
Revenue INR8.10B INR8.16B INR10.10B
EBITDA INR2.23B INR1.90B INR2.91B
Net Income INR12.19B INR1.50B INR2.04B
Total Assets INR46.33B INR INR30.54B
Total Cash INR2.86B INR INR5.96B
Total Debt INR INR INR276.10M

GLAXO Stock Price History

Glaxosmithkline Pharmaceuticals Limited Annual Stock Price History

Year Open Close Change
2021 INR1770.00 INR1500.00 -15.25%
2021 INR1607.20 INR1770.00 10.13%
2020 INR1615.00 INR1607.20 -0.48%

Glaxosmithkline Pharmaceuticals Limited Daily Stock Price History

Date Open High Low Close Change Volume
May 30, 2022 INR1520.00 INR1537.15 INR1515.00 INR1518.50 -1.86% 17.30K
Jun 10, 2022 INR1520.00 INR1563.65 INR1519.40 INR1547.25 2.35% 23.08K
Jun 7, 2022 INR1507.90 INR1515.00 INR1501.00 INR1511.70 -0.16% 12.07K

(NSE:GLAXO) Stock Price FAQs

What is today's stock price of Glaxosmithkline Pharmaceuticals Limited (NSE:GLAXO)?

  • The current stock price of Glaxosmithkline Pharmaceuticals Limited (NSE:GLAXO) is INR1500.00.
  • Today GLAXO stock price opened at INR1513.55 after previous close of INR1507.10.
  • During the day, Glaxosmithkline Pharmaceuticals Limited stock quote has varied from a low of INR1497.20 to a high of INR1521.80.

What is Glaxosmithkline Pharmaceuticals Limited's 52-week change?

  • GLAXO 52-week high stock quote is INR1918.75, which is 27.90% above the current share price.
  • The Glaxosmithkline Pharmaceuticals Limited (NSE:GLAXO) 52-week low stock price is INR1449.20, which is 3.40% below the current share price.
  • Glaxosmithkline Pharmaceuticals Limited share price volatility (52-week beta) is 0.18.

Glaxosmithkline Pharmaceuticals Limited (NSE:GLAXO) FAQ

How Much is Glaxosmithkline pharmaceuticals limited Worth?

Glaxosmithkline pharmaceuticals limited's worth today based on market capitalisation is INR254.56B

How much money does Glaxosmithkline pharmaceuticals limited make?

Last quarter (ended on March 31 ,2022) Glaxosmithkline pharmaceuticals limited generated a net income of INR12.19B, representing a 98.82% decrease compared to the same quarter a year before (ended on March 31 ,2021).
Last fiscal year (ended on March 31 ,2022) Glaxosmithkline pharmaceuticals limited generated a net income of INR16.95B, representing a 373.19% increase compare to the previous fiscal year (ended on March 31 ,2021).
View More Details on Glaxosmithkline pharmaceuticals limited's “Financials” Section

How much dividend does Glaxosmithkline pharmaceuticals limited Pay?

The current annualized dividend payout for GLAXO stock is INR30.00, the dividend yield is 1.98% and the payout ratio is 133.45%.
View More Details on Glaxosmithkline pharmaceuticals limited's "Dividend" Section

What is Glaxosmithkline pharmaceuticals limited’s Price to Earning (PE) ratio?

Glaxosmithkline pharmaceuticals limited has a Price to Earning (P/E) ratio of 15.00. GLAXO stock also has a Price to Sales (P/S) ratio of 7.77.

What is the Glaxosmithkline pharmaceuticals limited's ticker?

Glaxosmithkline pharmaceuticals limited trades on the NSE stock market in India under the ticker symbol "GLAXO". Glaxosmithkline pharmaceuticals limited’s stock symbol can also be displayed as "NSE:GLAXO".

Who are the owners of Glaxosmithkline pharmaceuticals limited?

Glaxosmithkline pharmaceuticals limited (NSE:GLAXO) is owned by 11.68% institutional shareholders and by 75.54% insiders. The rest is owned by the public.
Explore More Details on Glaxosmithkline pharmaceuticals limited's “Ownership” Section

Who are the key executives of Glaxosmithkline pharmaceuticals limited (GLAXO)?

Glaxosmithkline pharmaceuticals limited's key executive team includes the following managers:

  • Mr. Sridhar Venkatesh, MD & Director (NA)
  • Mr. Ajay A. Nadkarni, VP of Admin. & Real Estate and Company Sec. (NA)
  • Mr. Juby Chandy, Whole-Time Director & CFO (NA)
  • Mr. Abhinav Kashyap, VP of Technology & Pharma Technology Lead (NA)
  • Mr. Sankar Balasubramanian, Ethics & Compliance Officer (NA)
  • Mr. Amit G. Pandey, Exec. Vice-Pres of Legal (NA)
  • Mr. Ransom D'Souza, Exec. VP of Communications & Gov. Affairs (NA)
  • Mr. Chinmay Sharma, Exec. VP of HR (NA)
  • Mr. Sumer Dheri, Exec. VP of Biologicals (NA)
  • Mr. Bhushan Akshikar, Commercial Head of Established Pharma Bus. (NA)

What is Glaxosmithkline pharmaceuticals limited’s Sector & Industry Classification?

Glaxosmithkline pharmaceuticals limited (NSE:GLAXO) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.

How many employees work for Glaxosmithkline pharmaceuticals limited?

Currently the number of employees working for Glaxosmithkline pharmaceuticals limited is 0.

Where are Glaxosmithkline pharmaceuticals limited's Headquarters?

Glaxosmithkline pharmaceuticals limited (NSE:GLAXO) is headquartered in India.

What are Glaxosmithkline pharmaceuticals limited's Address and Phone Number?

Glaxosmithkline pharmaceuticals limited’s mailing address is GSK House, Mumbai, India, 400030.
The company’s phone number is 91 22 2495 9595.

What is the official website for Glaxosmithkline pharmaceuticals limited?

Glaxosmithkline pharmaceuticals limited’s official website is http://www.india-pharma.gsk.com